The Pfizer jab is so far still 93 per cent effective in preventing hospitalisation and serious illness, Israeli health officials say.
In late June, the Jewish state in occupied Palestine was experiencing a spike in coronavirus cases. A deeper look shows the Pfizer vaccine has proven to be effective in preventing serious illness.
It did not prevent an increase in new coronavirus cases (Delta) among those already vaccinated.
Israel’s Health Ministry reveals that vaccine effectiveness among those who have received two shots of the Pfizer/BioNTech jab dropped to as low as 64 per cent.
It is possible that almost one in every three fully vaccinated people in June and July were able get infected by Delta.
That’s the not so good news. Because even after vaccination, one should not venture about without following the COVID-19 SOPs. They are to keep social distancing, wear masks and sanitise hands and goods.
The good news is Pfizer is proving to be a tougher fighter against COVID-19.
The authorities agree that the rise in cases coincides with the ending of social distancing rules. It allows the Delta virus to flourish.
Health Ministry Allows Hospitals To Use Ivermectin “off-label”
Malaysia’s Health Ministry is allowing Hospitals to use the controversial ivermectin pills “off-label” and patients can ask for COVID-19 treatment.
The government was under pressure from various quarters to allow trials of the drug more commonly on animals.
Now it’s used to treat parasitic infections in humans and it is trending in Indonesia and India.
However, the WHO says evidence on the use of the deworming drug to treat Covid-19 patients is ‘inconclusive’.
Use of the drug in the pre-infection and early stages show it disrupts the virus replication. Ivermectin is said to flush out the viral debris that triggers immune response if the virus has set in.
It also helps to ease air duct congestion and heal some of the tissue damage.
